Good MorningThe market closed the day and the week lower on Friday. The week’s action was driven by a combination of fear and hope, fear that COVID 19 will cause another massive economic shutdown and hope that Congress will pass a stimulus bill. On the one hand, COVID-19 cases are on the rise with what is expected to be the worst of the pandemic still ahead of us. On the other, Congress passed a stop-gap measure to avoid a government shut-down for one week in hopes a stimulus bill can be passed.
Investors banking on another round of stimulus should take caution. If passed as is, the current stimulus bill is far less than the $2.8 trillion the summer stock market rally was built on. In that light, the passage of the bill could result in a sell-the-news event that takes the market back down to a firmer support zone.
Featured: New 5G "Arrow" to Replace Nuclear Missiles (BehindtheMarkets) 
|
Politics | | | Global stock markets were mostly lower Friday after U.S. unemployment claims rose in a sign of worsening economic damage from the coronavirus pandemic while Congress is deadlocked over possible new aid.
London, Tokyo and Shanghai retreated while Hong Kong and Seoul gained. U.S. stock ... Read the Full Story |
|
From Our PartnersThis hidden income strategy was just leaked and it can be yours now. It goes in depth about how you can start off with a small account and turn that into your own weekly paycheck. Learn how you can GAIN that extra advantage over what others aren't doing. | | Click here to get this secret |
|
Stocks | | | Even though many of these companies have had to deal with short-term issues caused by the pandemic, there’s a lot for investors to like about the companies that are keeping the world connected. Here are 3 telecom stocks that stand out at this time: Read the Full Story |
|
Markets | | |
With corporate borrowing rates at historic lows, most companies have opted to tap into the debt market to bolster liquidity and fund growth initiatives. But others have stayed clear of debt instead preferring to rely solely on the equity markets.
There are merits to both capital raising approache... Read the Full Story |
|
From Our PartnersWith most investors focused on big tech, a frenzy is quietly erupting in one tiny sector, with gains like 500% in two months and 104% in a single day. | | Click Here... |
|
Markets | | | Drugmakers GlaxoSmithKline and Sanofi said Friday that their potential COVID-19 vaccine won’t be ready until late next year because they need to improve the shot’s effectiveness in older people.
The companies said early trials showed the vaccine produced an “insufficient” immune respo... Read the Full Story |
|
Politics | | | Greek authorities say bookshops and hairdressers will be allowed to reopen beginning Monday but all other retail stores, entertainment venues, restaurants, bars and cafes will remain shut throughout the Christmas period as part of the country’s second lockdown Read the Full Story |
|
From Our PartnersInsiders at JPMorgan have come as close as humanly possible to a 100% trading record. Official documents show a 99.52% win rate for 6 years - with 3 years of ZERO down days. New research lets you "shadow" their trading desk and their awesome performance. | | The shocking details here. |
|
Politics | | | South Korea is expanding the use of rapid tests and deploying hundreds of police officers and soldiers to help with contact tracing as it deals with its worst surge of coronavirus cases since the early days of the pandemic Senior Health Ministry official Yoon Taeho said Friday that rapid antigen tests at emergency rooms, intensive-care units and remote-area hospitals will be covered by the national health insurance starting Monday, which would cost recipients about 8,000 won ($7) for each... Read the Full Story |
|
Politics | | | Australian Prime Minister Scott Morrison said Friday that his government won't rush approval of Pfizer’s coronavirus vaccine because he wants people to have confidence in the product
His comments come as Australian researchers said they were abandoning their own potential vaccine beca... Read the Full Story |
|
Markets | | | When the thing in question is common, and it's easy to meet demand, value declines accordingly. That's a point that Nio (NYSE:NIO) is testing out for itself, though it's still got a lot to like involved in it. Read the Full Story |
|
Markets | | | Johnson Outdoors (NASDAQ:JOUT) is one of those hum-drum investments that tends to not get much spotlight. The company makes outdoor electronics including trolling motors, depth finders, and other high-tech gear Read the Full Story |
|
Markets | | | Those disruptions are tied to the trade war (remember that?) and were only exacerbated by the pandemic. Now, three quarters into the crisis, operators like Hooker Furniture (NASDAQ:HOFT) are in a rebound that will last for at least another three. Read the Full Story |
|
The Early Bird Stock Of The Day Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. | | View Today's Stock Pick |
|
